Frequency of the off-label use of antibiotics in clinical practice: a systematic review

References

• Garazzino S, Tovo PA. Clinical experience with linezolid in infants and children. J. Antimicrob. Chemother. 66(Suppl. 4), iv23–iv41 (2011).
   PubMed Web of Science ®Google Scholar
• van Rappard DC, Limpens J, Mekkes JR. The off-label treatment of severe hidradenitis suppurativa with TNF-α inhibitors: a systematic review. J. Dermatolog. Treat. doi:10.3109/09546634.2012.674193 (2012) (Epub ahead of print).
   Google Scholar
• Turner S, Nunn AJ, Fielding K, Choonara I. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr. 88(9), 965–968 (1999).
   PubMed Web of Science ®Google Scholar
• Ufer M, Kimland E, Bergman U. Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden. Pharmacoepidemiol. Drug Saf. 13(3), 147–152 (2004).
   PubMed Web of Science ®Google Scholar
• Conroy S, Choonara I, Impicciatore P et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. BMJ 320(7227), 79–82 (2000).
   PubMed Web of Science ®Google Scholar
• de Jong J, van den Berg PB, Visser ST, de Vries TW, de Jong-van den Berg LT. Antibiotic usage, dosage and course length in children between 0 and 4 years. Acta Paediatr. 98(7), 1142–1148 (2009).
   PubMedGoogle Scholar
• Jain SS, Bavdekar SB, Gogtay NJ, Sadawarte PA. Off-label drug use in children. Indian J. Pediatr. 75(11), 1133–1136 (2008).
   PubMedGoogle Scholar
• Lass J, Käär R, Jõgi K, Varendi H, Metsvaht T, Lutsar I. Drug utilisation pattern and off-label use of medicines in Estonian neonatal units. Eur. J. Clin. Pharmacol. 67(12), 1263–1271 (2011).
   PubMed Web of Science ®Google Scholar
• McIntyre J, Conroy S, Avery A, Corns H, Choonara I. Unlicensed and off label prescribing of drugs in general practice. Arch. Dis. Child. 83(6), 498–501 (2000).
   PubMed Web of Science ®Google Scholar
• Pandolfini C, Impicciatore P, Provasi D, Rocchi F, Campi R, Bonati M; Italian Paediatric Off-label Collaborative Group. Off-label use of drugs in Italy: a prospective, observational and multicentre study. Acta Paediatr. 91(3), 339–347 (2002).
   PubMed Web of Science ®Google Scholar
• Brosgart CL, Mitchell T, Charlebois E et al. Off-label drug use in human immunodeficiency virus disease. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 12(1), 56–62 (1996).
   PubMedGoogle Scholar
• Herring C, McManus A, Weeks A. Off-label prescribing during pregnancy in the UK: an analysis of 18,000 prescriptions in Liverpool Women’s Hospital. Int. J. Pharm. Pract. 18(4), 226–229 (2010).
   PubMedGoogle Scholar
• Rayburn WF, Turnbull GL. Off-label drug prescribing on a state university obstetric service. J. Reprod. Med. 40(3), 186–188 (1995).
   PubMedGoogle Scholar
• Stone KJ, Viera AJ, Parman CL. Off-label applications for SSRIs. Am. Fam. Physician 68(3), 498–504 (2003).
   PubMed Web of Science ®Google Scholar
• Albaladejo P, Caillet B, Moine P, Vigué B, Decorps-Declère A, Benhamou D. [Off-label prescriptions in an adult surgical intensive care unit]. Presse Med. 30(30), 1484–1488 (2001).
   PubMedGoogle Scholar
• Barr J, Brenner-Zada G, Heiman E et al. Unlicensed and off-label medication use in a neonatal intensive care unit: a prospective study. Am. J. Perinatol. 19(2), 67–72 (2002).
   PubMed Web of Science ®Google Scholar
• Conde-Estévez D, Grau S, Horcajada JP, Luque S. Off-label prescription of tigecycline: clinical and microbiological characteristics and outcomes. Int. J. Antimicrob. Agents 36(5), 471–472 (2010).
   PubMedGoogle Scholar
• Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch. Dis. Child. Fetal Neonatal Ed. 80(2), F142–F144; discussion F144 (1999).
   PubMed Web of Science ®Google Scholar
• Curcio D. Off-label use of antibiotics in hospitalized patients: focus on tigecycline. J. Antimicrob. Chemother. 64(6), 1344–1346 (2009).
   PubMed Web of Science ®Google Scholar
• Curcio D, Fernández F, Cané A, Barcelona L, Stamboulian D. Indications of a new antibiotic in clinical practice: results of the tigecycline initial use registry. Braz. J. Infect. Dis. 12(3), 198–201 (2008).
   PubMed Web of Science ®Google Scholar
• Curcio D, Fernández F, Duret F. [Initial use of tigecycline in Argentina]. Rev. Chilena Infectol. 24(6), 497–499 (2007).
   PubMed Web of Science ®Google Scholar
• Gleason PP, Walters C, Heaton AH, Schafer JA. Telithromycin: the perils of hasty adoption and persistence of off-label prescribing. J. Manag. Care Pharm. 13(5), 420–425 (2007).
   PubMed Web of Science ®Google Scholar
• Lat I, Micek S, Janzen J, Cohen H, Olsen K, Haas C. Off-label medication use in adult critical care patients. J. Crit. Care 26(1), 89–94 (2011).
   PubMed Web of Science ®Google Scholar
• Manfredi R, Nanetti A, Dal Monte P, Calza L. Increasing pathomorphism of pulmonary tuberculosis: an observational study of slow clinical, microbiological and imaging response of lung tuberculosis to specific treatment. Which role for linezolid? Braz. J. Infect. Dis. 13(4), 297–303 (2009).
   PubMed Web of Science ®Google Scholar
• Neubert A, Lukas K, Leis T, Dormann H, Brune K, Rascher W. Drug utilisation on a preterm and neonatal intensive care unit in Germany: a prospective, cohort-based analysis. Eur. J. Clin. Pharmacol. 66(1), 87–95 (2010).
   PubMed Web of Science ®Google Scholar
• Porta A, Esposito S, Menson E et al. Off-label antibiotic use in children in three European countries. Eur. J. Clin. Pharmacol. 66(9), 919–927 (2010).
   PubMed Web of Science ®Google Scholar
• Radley DC, Finkelstein SN, Stafford RS. Off-label prescribing among office-based physicians. Arch. Intern. Med. 166(9), 1021–1026 (2006).
   PubMed Web of Science ®Google Scholar
• Santos DB, Clavenna A, Bonati M, Coelho HL. Off-label and unlicensed drug utilization in hospitalized children in Fortaleza, Brazil. Eur. J. Clin. Pharmacol. 64(11), 1111–1118 (2008).
   PubMedGoogle Scholar
• ‘t Jong GW, van der Linden PD, Bakker EM et al. Unlicensed and off-label drug use in a paediatric ward of a general hospital in The Netherlands. Eur. J. Clin. Pharmacol. 58(4), 293–297 (2002).
   PubMed Web of Science ®Google Scholar
• Zhou Q, Zhu LL, Yan XF, Pan WS, Zeng S. Drug utilization of clarithromycin for gastrointestinal disease treatment. World J. Gastroenterol. 14(39), 6065–6071 (2008).
   PubMedGoogle Scholar
• Lifshitz M, Gavrilov V, Grossman Z et al. Unapproved prescription practices in primary pediatric clinics in Israel: a prospective analysis. Curr. Ther. Res. Clin. Exp. 63(12), 830–837 (2002).
   Google Scholar
• ‘t Jong GW, Eland IA, de Hoog M, Sturkenboom M, van den Anker JN, Stricker BH. Unlicensed and off-label prescription of systemic anti-infective agents to children. Pediatr. Perinatal Drug Ther. 5(2), 71–77 (2002).
   Google Scholar
• Gavrilov V, Lifshitz M, Levy J, Gorodischer R. Unlicensed and off-label medication use in a general pediatrics ambulatory hospital unit in Israel. Isr. Med. Assoc. J. 2(8), 595–597 (2000).
   PubMed Web of Science ®Google Scholar
• Dell’Aera M, Gasbarro AR, Padovano M et al. Unlicensed and off-label use of medicines at a neonatology clinic in Italy. Pharm. World Sci. 29(4), 361–367 (2007).
   PubMed Web of Science ®Google Scholar
• Fridkin SK, Gaynes RP. Antimicrobial resistance in intensive care units. Clin. Chest Med. 20(2), 303–16, viii (1999).
   PubMed Web of Science ®Google Scholar
• Rose K, Della Pasqua O. Development of paediatric medicines: concepts and principles. Handb. Exp. Pharmacol. 205, 111–124 (2011).
   PubMedGoogle Scholar
• Ceci A, Felisi M, Baiardi P et al. Medicines for children licensed by the European Medicines Agency (EMEA): the balance after 10 years. Eur. J. Clin. Pharmacol. 62(11), 947–952 (2006).
   PubMed Web of Science ®Google Scholar
• d’Aloja E, Paribello F, Demontis R, Müller M. Off-label drugs prescription in neonatology: a physician’s duty or a medical hazardous attitude? J. Matern. Fetal. Neonatal. Med. 24(Suppl. 1), 99–100 (2011).
   PubMed Web of Science ®Google Scholar
• Tobin JR. Use of pharmaceuticals ‘off-label’ in the neonate. Best Pract. Res. Clin. Anaesthesiol. 24(3), 451–460 (2010).
   PubMedGoogle Scholar
• Davies EH, Ollivier CM, Saint Raymond A. Paediatric investigation plans for pain: painfully slow! Eur. J. Clin. Pharmacol. 66(11), 1091–1097 (2010).
   PubMedGoogle Scholar
• Giamarellou H, Poulakou G. Multidrug-resistant Gram-negative infections: what are the treatment options? Drugs 69(14), 1879–1901 (2009).
   PubMed Web of Science ®Google Scholar
• Giménez MJ, García-Rey C, Barberán J, Aguilar L. [Clinical experience with tigecycline in the treatment of nosocomial infections caused by isolates exhibiting prevalent resistance mechanisms]. Rev. Esp. Quimioter. 22(1), 48–56 (2009).
   PubMedGoogle Scholar
• Bonati M, Pandolfini C. Off-label drug use in children should be rational. Arch. Dis. Child. 96(9), 870–871 (2011).
   PubMedGoogle Scholar